Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Department of Microbiology, Fujita Health University, Toyoake, Aichi, Japan.
J Clin Microbiol. 2017 Dec 26;56(1). doi: 10.1128/JCM.01368-17. Print 2018 Jan.
Fosfomycin maintains activity against most clinical isolates, but the growth of colonies within the zone of inhibition around the fosfomycin disk is occasionally observed upon susceptibility testing. We aimed to estimate the frequency of such nonsusceptible inner colony mutants and identify the underlying resistance mechanisms. Disk diffusion testing of fosfomycin was performed on 649 multidrug-resistant clinical isolates collected between 2011 and 2015. For those producing inner colonies inside the susceptible range, the parental strains and their representative inner colony mutants were subjected to MIC testing, whole-genome sequencing, reverse transcription-quantitative PCR (qRT-PCR), and carbohydrate utilization studies. Of the 649 clinical isolates, 5 (0.8%) consistently produced nonsusceptible inner colonies. Whole-genome sequencing revealed the deletion of encoding hexose-6-phosphate antiporter in 4 of the inner colony mutants, while the remaining mutant contained a nonsense mutation in The expression of was absent in the mutant strains with deletion and was not inducible in the strain with the mutation, unlike in its parental strain. All 5 inner colony mutants had reduced growth on minimal medium supplemented with glucose-6-phosphate. In conclusion, fosfomycin-nonsusceptible inner colony mutants can occur due to the loss of function or induction of UhpT but are rare among multidrug-resistant clinical strains. Considering that these mutants carry high biological costs, we suggest that fosfomycin susceptibility of strains that generate inner colony mutants can be interpreted on the basis of the zone of inhibition without accounting for the inner colonies.
磷霉素对大多数临床分离株仍保持活性,但在药敏试验时偶尔会观察到抑菌圈内的菌落生长。我们旨在评估这种非敏感性的内菌落突变体的频率,并确定潜在的耐药机制。对 2011 年至 2015 年间收集的 649 株多药耐药临床分离株进行磷霉素的纸片扩散试验。对于那些在敏感范围内产生内菌落的菌株,对亲本株及其代表性的内菌落突变株进行 MIC 检测、全基因组测序、逆转录定量 PCR(qRT-PCR)和碳水化合物利用研究。在 649 株临床分离株中,有 5 株(0.8%)始终产生非敏感性的内菌落。全基因组测序显示 4 株内菌落突变株中编码己糖-6-磷酸转运蛋白的基因缺失,而其余突变株则在 中存在无义突变。缺失 突变株中 的表达缺失,而在 突变株中则无诱导表达,与亲本株不同。所有 5 株内菌落突变株在添加葡萄糖-6-磷酸的最小培养基上的生长均减少。总之,由于 UhpT 的功能丧失或诱导,可能会出现磷霉素不敏感的内菌落突变体,但在多药耐药的临床菌株中较为罕见。考虑到这些突变株携带高生物成本,我们建议对于产生内菌落突变体的菌株,无需考虑内菌落,仅根据抑菌圈即可解释其对磷霉素的敏感性。